BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

983 related articles for article (PubMed ID: 23593783)

  • 1. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection.
    Contreras AM; Ochoa-Jiménez RJ; Celis A; Méndez C; Olivares L; Rebolledo CE; Hernandez-Lugo I; Aguirre-Zavala AI; Jiménez-Méndez R; Chung RT
    Transfusion; 2010 Jun; 50(6):1335-43. PubMed ID: 20088833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
    Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
    Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
    Sayan M; Meriç M; Mutlu B; Celebi S; Willke A
    Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon.
    Njouom R; Tejiokem MC; Zanga MC; Pouillot R; Ayouba A; Pasquier C; Nerrienet E
    J Virol Methods; 2006 May; 133(2):223-6. PubMed ID: 16360220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H; Navaratnam V; Asjø B
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus.
    Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP
    J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and characteristics of nine anti-HCV antibody screening reagents used in Japan.
    Kita M; Deguchi M; Kagita M; Yoshioka N; Kobayashi E; Watanabe M; Asari S; Yamanaka K; Iwatani Y
    Clin Lab; 2009; 55(1-2):9-22. PubMed ID: 19350845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing.
    Contreras AM; Tornero-Romo CM; Toribio JG; Celis A; Orozco-Hernández A; Rivera PK; Méndez C; Hernández-Lugo MI; Olivares L; Alvarado MA
    Transfusion; 2008 Dec; 48(12):2540-8. PubMed ID: 18680546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection].
    Payan C; Raimbert A; Fouchard-Hubert I; Kouyoumdjian S; Lunel-Fabiani F
    Ann Biol Clin (Paris); 2003; 61(3):311-7. PubMed ID: 12805008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
    Wu S; Liu Y; Cheng L; Yin B; Peng J; Sun Z
    J Med Virol; 2011 Nov; 83(11):1930-7. PubMed ID: 21915868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
    Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
    Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions.
    Berger A; Rabenau H; Allwinn R; Doerr HW
    J Clin Virol; 2008 Oct; 43(2):158-61. PubMed ID: 18635393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.